|
| 08.07.2009 |
VALEOVOX, INC. NAMES PAUL LEVESQUE CHIEF EXECUTIVE OFFICER
Boston – August 7, 2009 –– ValeoVox co-founder and President Amelia Spiliotes announced today that Paul Levesque has been named the new chief executive officer of ValeoVox, a technology solutions firm that develops customized product applications and workflow processes for disease management.
Formerly a vice president of sales and marketing for a division of Wyeth Laboratories in Connecticut, Levesque brings to ValeoVox over 20 years of experience in biomedical technology and healthcare industries. He also served as chief operating officer of Predictive Sciences, an internet start-up that focuses on chronic disease management and a senior healthcare consultant at management consulting firm Arthur D. Little, Inc.
“We are delighted to welcome Paul to our team at ValeoVox,” said Amelia Spiliotes. “His experience in the healthcare business combined with an in-depth understanding of new product and technology development and licensing collaborations will enhance our efforts to build a strong business.”
Prior to joining ValeoVox, Levesque founded and served as managing director of Cardiocare Inc., a start up division of a North Carolina based diagnostics provider that delivered on-site neurologic and cardiovascular diagnostics to primary care physicians though an innovative business and reimbursement model. He has also led launches of a number of new product platforms with leading universities and medical institutions such as Stanford University, National Institutes of Health, University of Chicago, University of Alberta and Boston University.
Levesque holds a bachelors degree in engineering from the US Merchant Marine Academy and a master’s degree in Biomedical Engineering from Worcester Polytechnic Institute.
About Valeovox
ValeoVox is a broad-based consulting and software development company that concentrates on providing solutions to workflow processes and patient management for hospitals, group practices and community health organizations. The company recently launched its e-WP product, a web-enabled care coordination program which, when applied to specific diseases such as diabetes, depression, cancer, orthopedics and cardiac rehab, aids caregivers to communicate thoroughly and effectively and therefore better manage patient care.
|
| |
|
Power your growth using our products and services. Contact us today for more information.
|
